Personalized Medicine News and Research

RSS

Standard cutoff point for low testosterone levels may not be accurate for young men

The standard cutoff point for low testosterone levels may not be accurate for men in their mid-forties and younger, reports a study in The Journal of Urology, an Official Journal of the American Urological Association (AUA).

28 Oct 2022

Cancer cells' sticky fingers contribute to building a barrier surrounding breast tumors

Researchers at Turku University and Åbo Akademi University, Finland, have identified that finger-like cellular extensions called filopodia contribute to building a barrier surrounding breast tumors.

28 Oct 2022

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

In a recent study published in The Journal of Allergy and Clinical Immunology, researchers in New Zealand gathered evidence to show that selective immunoglobulin A deficiency (sIgAD) is an understated risk factor for severe coronavirus disease 2019 (COVID-19).

17 Oct 2022

Understanding the potential applications of stem cell research

To mark Stem Cell Awareness Day on October 12, 2022, COST is highlighting a network of researchers working to foster greater understanding about stem cell research and potential applications for millions of people suffering from incurable diseases and injury.

12 Oct 2022

The Increasing Use of Microfluidics in Labs and Hospitals

This interview from Bartels discusses how microfluidics will be used increasingly in labs, hospitals and doctors offices in the future. Bartels provides its clients with fast and easy entry into the microfluidics field.

From Bartels Mikrotechnik GmbH 4 Oct 2022

Study reviews the power of mobile sensing in the COVID-19 era

Mobile sensing has shown its power in the pervasive and effective monitoring of COVID-19 in varying population scales and time duration, according to a study published in Health Data Science, a Science Partner Journal.

23 Sep 2022

UC San Diego team receives $1.2 million to create a novel system to study chronic low back pain

A multidisciplinary team led by researchers at UC San Diego has received $1.2 million from the National Science Foundation to create a novel system to study and inform the treatment of chronic low back pain.

20 Sep 2022

Study establishes a direct link between disruption of circadian clocks and lipid changes in diabetics

A team from Geneva, Switzerland, shows that the disruption of lipid temporal profiles in type 2 diabetes stiffens the membrane of pancreatic endocrine cells, which could alter their function.

19 Sep 2022

Researchers use data from wearables to predict outcomes of depression treatment

Over the past several years, managing one's mental health has become more of a priority with an increased emphasis on self-care. Depression alone affects more than 300 million people worldwide annually.

13 Sep 2022

In vitro skeletal muscle models could lead to personalized medicine for type 2 diabetes

Abnormally high blood sugar (glucose) levels can result in Type 2 diabetes when things go awry with the body's skeletal muscle, which plays a key role in regulating glucose.

13 Sep 2022

Researchers join forces to 'map' specific variations in more than 25 key cardiac disease genes

One in 100 people have genetic variations that can cause potentially life-threatening heart conditions, including high cholesterol (lipid disorders), heart muscle disease (cardiomyopathies), and abnormal heart rhythms (arrhythmias).

13 Sep 2022

Gut microbes can also impact a person's neurological and emotional health, UTSW researcher says

The role of the microbiome in intestinal and systemic health has garnered close attention among researchers for many years.

9 Sep 2022

New tool uses artificial intelligence to calculate harmful effects of medicines

Research led by the University of Exeter and Kent and Medway NHS and Social Care Partnership Trust, published in Age and Ageing, assessed a new tool designed to calculate which medicines are more likely to experience adverse anticholinergic effects on the body and brain.

7 Sep 2022

People of African-Caribbean heritage living with diabetes have greater kidney disease risk

New research confirms for the first time that ethnicity is a risk factor for developing kidney disease in people with Type 1 diabetes.

1 Sep 2022

No one-size-fits-all AI program exists for all preventive treatments

A Rutgers analysis of dozens of artificial intelligence (AI) software programs used in precision, or personalized, medicine to prevent, diagnose and treat disease found that no program exists that can be used for all treatments.

18 Aug 2022

Mount Sinai and Regeneron Genetics Center launch a new human genome sequencing research project

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.

12 Aug 2022

International medical experts aim to use biomarker-based approaches to advance precision medicine

The diagnostics company SphingoTec GmbH (SphingoTec), announces that, during the 4th Scientific Symposium held near Potsdam, Germany, international medical experts discussed the latest developments in diagnostic and therapeutic innovations for advancing precision medicine in critically ill patients.

11 Aug 2022

Study demonstrates the success rate of gene analysis using cytological specimens to be extremely high

Personalized medicine for lung cancer using molecular-targeted drugs is common but there have been no prospective validation studies done on the usefulness of lung cancer gene panel testing using cytology samples.

8 Aug 2022

Study provides new insight into the cellular and molecular biology of human heart failure

Studying heart samples from patients with cardiomyopathies, as well as from controls without heart disease, researchers have provided new insights into the cellular and molecular biology of human heart failure – a highly fatal condition that affects 23 million people worldwide.

5 Aug 2022

Individual genetic defects lead to heart failure in different ways, consortium reports

Cardiomyopathy is not a uniform disease. Rather, individual genetic defects lead to heart failure in different ways, an international consortium reports in Science.

4 Aug 2022

Personalized Medicine News and Research

Standard cutoff point for low testosterone levels may not be accurate for young men

Cancer cells' sticky fingers contribute to building a barrier surrounding breast tumors

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

Understanding the potential applications of stem cell research

The Increasing Use of Microfluidics in Labs and Hospitals

Study reviews the power of mobile sensing in the COVID-19 era

UC San Diego team receives $1.2 million to create a novel system to study chronic low back pain

Study establishes a direct link between disruption of circadian clocks and lipid changes in diabetics

Researchers use data from wearables to predict outcomes of depression treatment

In vitro skeletal muscle models could lead to personalized medicine for type 2 diabetes

Researchers join forces to 'map' specific variations in more than 25 key cardiac disease genes

Gut microbes can also impact a person's neurological and emotional health, UTSW researcher says

New tool uses artificial intelligence to calculate harmful effects of medicines

People of African-Caribbean heritage living with diabetes have greater kidney disease risk

No one-size-fits-all AI program exists for all preventive treatments

Mount Sinai and Regeneron Genetics Center launch a new human genome sequencing research project

International medical experts aim to use biomarker-based approaches to advance precision medicine

Study demonstrates the success rate of gene analysis using cytological specimens to be extremely high

Study provides new insight into the cellular and molecular biology of human heart failure

Individual genetic defects lead to heart failure in different ways, consortium reports

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News